APNN Applied Nanoscience Inc. featured news, full reports, and detailed charts
Applied Nanoscience Inc. (APNN/APNN.PK) Wrap Up:
Applied Nanoscience, Inc. focuses on commercializing Nanoparticle-Enhanced-Filtration-Technology platform (NEFT) in the United States. The NEFT platform filters bacteria and viruses from the air, and acts as a destructive adsorbent to destroy microorganisms that come in contact with the filtration media. The platform could be customized to various applications, including emergency response, transportation, and shelter/building ventilation. The company was founded in 2004 and is based in Carlsbad, California.Applied Nanoscience Inc. (APNN:OTC)
|
Market Cap
4.9M
|
Total Revenue
53.5K
|
|
|
EBITDA
1.4M
|
DILUTED EPS TTM
-0.08
|
|
|
P/E
--
|
P/S
NM
|
|
|
Return On Asset
--
|
Return On Equity
--
|
|
| K = Thousands M = Millions B = Billions | ||
APNN Top Compensated Officers
Executives, Board Directors
Key developments for Applied Nanoscience Inc. (APNN)
Applied Nanoscience Inc. announced the election of Staffan Lofgren to its board of directors. Lofgren is the managing director of ScanAsia Consulting Ltd. He brings extensive international business expertise specifically in the markets of primary interest and focus for the joint venture product launch of the disposable NanoFense(TM) Protective Face Mask. Lofgren was elected to replace Patrick J. Gorman on the ANI board who remains in a financial capacity with the company.
Applied Nanoscience Inc. announced it has reached a joint venture agreement to begin production on a disposable protective face mask with its Asia Pacific region partner. The protective mask will incorporate ANI's proprietary NanoFenseTM technology, a U.S. patent pending antimicrobial nanoparticle formulation. When tested as a 'coating' on disposable face masks, it has been validated to be effective against a broad spectrum of virus and bacteria by multiple independent BSL-3 laboratories in the United States. ANI will be testing the NanoFense formulation against H1N1 but with the mask already proven to eradicate three influenza strains to include avian influenza, the company expects to see similarly high efficacy. The companies have clearly defined the commercial relationship required and to be implemented in the execution of a product launch to non-U.S. markets for the NanoFense Protective Face Mask. Initial production will be 30,000 masks/day with the capability of increasing up to 90,000 masks/day on newly installed automatic equipment which operates 7 days a week. ANI will supply the NanoFense formulation premixed under their label.
Applied Nanoscience Inc. announced it has reached an agreement to collaborate on a surgical/protective mask application of the Company's NEFT(TM) platform with a medical disposables company in the Asia Pacific region. Both companies intend to clearly define the commercial relationship required and to be implemented as part of the formal license agreement. The licensure of ANI's broad IP platform encompassing 'Filtering Devices Incorporating Nanoparticles,' will be combined with a separate license of ANI's NanoFense(TM) formulation, a proprietary antimicrobial nanoparticle 'coating' which can be applied to virtually any existing filter media.
APNN Competitors
| Company | Last | Change | |
| No competitor information is available for APNN. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | APNN | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | NM | Not Meaningful |
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
APNN |
||
APNN transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
